Livzon Pharma Releases 2025 Annual Report and AGM Documentation Online

Bulletin Express

04/23

On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk):

• 2025 Annual Report • Circular dated 23 April 2026 • Notice and Proxy Form for the 2025 Annual General Meeting • Notice and Proxy Form for the 2026 First Class Meeting of H-Shareholders

The board recommends shareholders and investors review the digital versions to ensure timely access to information. Non-registered holders experiencing difficulty with electronic access may obtain printed copies free of charge by completing the enclosed request form and sending it to the Hong Kong branch share registrar, Tricor Investor Services Ltd., at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.

Stakeholders wishing to switch to electronic delivery must provide a functional email address through their respective banks, brokers, custodians, nominees, or HKSCC Nominees Ltd. Until a valid email address is registered, non-registered holders will continue to receive hard-copy notices of publication.

Enquiries can be directed to Tricor Investor Services’ hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m. (excluding public holidays).

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1105246407"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105246407\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105246407?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105246407","market":"hk","top_or_hot":-1,"title":"Livzon Pharma Releases 2025 Annual Report and AGM Documentation Online","media":"Bulletin Express","content":"<p>On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk):</p>\n<p>• 2025 Annual Report  \n• Circular dated 23 April 2026  \n• Notice and Proxy Form for the 2025 Annual General Meeting  \n• Notice and Proxy Form for the 2026 First Class Meeting of H-Shareholders</p>\n<p>The board recommends shareholders and investors review the digital versions to ensure timely access to information. Non-registered holders experiencing difficulty with electronic access may obtain printed copies free of charge by completing the enclosed request form and sending it to the Hong Kong branch share registrar, Tricor Investor Services Ltd., at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.</p>\n<p>Stakeholders wishing to switch to electronic delivery must provide a functional email address through their respective banks, brokers, custodians, nominees, or HKSCC Nominees Ltd. Until a valid email address is registered, non-registered holders will continue to receive hard-copy notices of publication.</p>\n<p>Enquiries can be directed to Tricor Investor Services’ hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m. (excluding public holidays).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma Releases 2025 Annual Report and AGM Documentation Online</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma Releases 2025 Annual Report and AGM Documentation Online\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-23 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk):</p>\n<p>• 2025 Annual Report  \n• Circular dated 23 April 2026  \n• Notice and Proxy Form for the 2025 Annual General Meeting  \n• Notice and Proxy Form for the 2026 First Class Meeting of H-Shareholders</p>\n<p>The board recommends shareholders and investors review the digital versions to ensure timely access to information. Non-registered holders experiencing difficulty with electronic access may obtain printed copies free of charge by completing the enclosed request form and sending it to the Hong Kong branch share registrar, Tricor Investor Services Ltd., at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.</p>\n<p>Stakeholders wishing to switch to electronic delivery must provide a functional email address through their respective banks, brokers, custodians, nominees, or HKSCC Nominees Ltd. Until a valid email address is registered, non-registered holders will continue to receive hard-copy notices of publication.</p>\n<p>Enquiries can be directed to Tricor Investor Services’ hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m. (excluding public holidays).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1105246407","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105246407","pubTimestamp":1776955435,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药在线发布2025年年度报告及年度股东大会文件","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"On 23 April 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that the following corporate documents are now available on both the company website (www.livzon.com.cn) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk):\n• 2025 Annual Report  \n• Circular dated 23 April 2026  \n• Notice and Proxy Form for the 2025 Annual General Meeting  \n• Notice and Proxy Form for the 2026 First Class Meeting of H-Shareholders\nThe board recommends shareholders and investors review the digital versions to ensure timely access to information. Non-registered holders experiencing difficulty with electronic access may obtain printed copies free of charge by completing the enclosed request form and sending it to the Hong Kong branch share registrar, Tricor Investor Services Ltd., at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1513-ecom@vistra.com.\nStakeholders wishing to switch to electronic delivery must provide a functional email address through their respective banks, brokers, custodians, nominees, or HKSCC Nominees Ltd. Until a valid email address is registered, non-registered holders will continue to receive hard-copy notices of publication.\nEnquiries can be directed to Tricor Investor Services’ hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m. (excluding public holidays).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}